ERBIN and ductal breast carcinoma in situ: We found significant increase in ERBIN expression in DCIS and invasive tumor areas as compared to non-malignant and myoepithelial cells, although the absolute increase appeared greater for DCIS than for invasive tumor (Fig. 2H-I).